Navigating the smarter
path to stable cell lines
in cell line development
Stable, robust cell lines are the engines driving biologics
production and biomedical research, but developing them involves
a series of careful steps. Along the way, researchers face challenges
that can slow progress or affect clone quality — but with the right
tools and strategies, they can fast-track development and build cell
lines that move science forward.
Host cell line selection
The process begins with selecting a host cell
line that’s biologically relevant, genetically
stable, contaminant-free, and suited to the
experimental goals.
Challenge:
Selection bias — clones chosen based
on early traits that may not predict
long-term performance
Strategy:
Include a mix of high- and medium
producing
clones to ensure a fair
chance to identify those that maintain
stability, quality, and growth over time
Plasmid design
Selectable
and construction
Marker
Promoter
Researchers design and assemble a plasmid vector carrying
the gene of interest (GOI) along with essential regulatory
elements, creating a construct ready for delivery into the
host cells.
Inserted
Restriction
Challenge:
Gene
Sites
Achieving efficient, stable, and high-level GOI
expression
Strategy:
Origin of
Design expression vectors with synthetic
Replication
promoters, robust selection markers, and selection
marker attenuation to enhance yields of high
Antibiotic
producing
clones
Resistance Gene
Transfection
Researchers introduce the plasmid construct into host
cells using transfection methods such as electroporation
or lipofection, so that host cells take up the foreign DNA
and begin expressing the target protein.
Challenge:
Random GOI integration into the genome,
resulting in inconsistent and unpredictable
protein expression
Strategy:
Incorporate site-specific integration techniques
like genome editing tools to ensure precise gene
insertion and reduce clonal variation
Challenge:
Cell cloning
Low efficiency and high variability in
traditional methods, which often rely
and selection
on manual handling and extensive
screening
After transfection, researchers screen
Strategy:
the cell population, identify the ones that
successfully express the target protein, and
Use automated techniques like Cyto-Mine®
clone these cells individually to establish
Single Cell Analysis Platform to screen,
monoclonal populations.
sort, and isolate top clones in one workflo
Cyto-Mine®
CHR
MA
Cyto-Mine®
CHR
MA
Image & Dispense
Encapsulate
Assay
Sort
Capture images for
Isolate up to 400,000
Screen each cell for
Select top performers
monoclonality assurance
single cells in
antibody secretion
based on fluorescenc
and dispense selected cells
picodroplets
into 96- or 384- well plates
Automated Workflow (4-8 Hours)
Built on picodroplet technology, Cyto-Mine encapsulates individual cells in tiny droplets, each acting as a mini
bioreactor. It then rapidly screens millions of cells for target protein expression, sorts high-performing cells, and
precisely dispenses single cells into wells, eliminating hands-on time and reducing contamination.
Clone expansion
After identifying top clones, researchers expand these
cells under controlled conditions, monitoring their
stability, productivity, and quality over time.
Challenge:
Clones may lose performance during scale-up
due to changes in culture conditions
Strategy:
Apply stepwise expansion and early analytics,
such as Cyto-Mine, to track performance and
identify optimal growth conditions
Paving the way for scalable,
reproducible research
Optimizing each step of the cell line development
process allows scientists to generate high-performing
cell lines that support efficient and reliable research.
With advanced automated solutions like Cyto-
Mine, researchers can scale discoveries and drive
reproducible results from early-stage research through
therapeutic development.
